Skip to main content
Koji Takeda, MD, Thoracic Surgery, New York, NY, New York-Presbyterian Hospital

KojiTakedaMDPhD

Thoracic Surgery New York, NY

Adult Cardiac Surgery, Cardiopulmonary Transplantation, Minimally Invasive Cardiac Surgery

Assistant Professor of Surgery

Overview of Dr. Takeda

Dr. Koji Takeda is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, NewYork-Presbyterian/Allen Hospital, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Osaka University Medical School and has been in practice 18 years. He is one of 141 doctors at New York-Presbyterian Hospital and one of 14 doctors at NewYork-Presbyterian/Allen Hospital who specialize in Thoracic Surgery. He also speaks multiple languages, including Japanese. He has more than 100 publications and over 500 citings.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Thoracic Surgery, 2012
  • Osaka University Medical School
    Osaka University Medical SchoolClass of 1999

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • NY State Medical License
    NY State Medical License 2012 - 2024
  • CT State Medical License
    CT State Medical License 2021 - 2024
  • IL State Medical License
    IL State Medical License 2010 - 2012

Publications & Presentations

PubMed

Journal Articles

  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019  
    Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
  • VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?  
    Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation

Authored Content

  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020

Press Mentions

  • The Power of Medicine
    The Power of MedicineMay 17th, 2023
  • Efficacy of Osimertinib plus Bevacizumab vs Osimertinib in Patients with EGFR T790M–Mutated Non–Small Cell Lung Cancer Previously Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
    Efficacy of Osimertinib plus Bevacizumab vs Osimertinib in Patients with EGFR T790M–Mutated Non–Small Cell Lung Cancer Previously Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase InhibitorJanuary 7th, 2021
  • Phase II Study of Nimotuzumab in Combination with Concurrent Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer
    Phase II Study of Nimotuzumab in Combination with Concurrent Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung CancerDecember 26th, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • Japanese

Hospital Affiliations